Supplementary File 3 from Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes

Components of tumor development TAp63 (3.1) and Î"Np63 (3.2) signatures used in this study. Pathways enriched in TAp63 (3.3) and Î"Np63 (3.4) tumor development signatures.